Transcriptomics

Dataset Information

0

Loss of the immunomodulatory transcription factor BATF2 in humans is associated with a neurological phenotype


ABSTRACT: Epilepsy and mental retardation are known to be associated with pathogenic mutations of a broad range of genes that are expressed in the brain and play a role in neurodevelopment. Here, we report a family with three affected individuals whose clinical symptoms closely resemble a neurodevelopmental disorder. Whole-exome sequencing identified a homozygous stop-gain mutation p.Q19* in the BATF2 gene in the patients. The BATF2 transcription factor is predominantly expressed in macrophages and monocytes, and has been reported to modulate AP-1 transcription factor-mediated pro-inflammatory responses. Transcriptome analysis showed an altered base-level expression of interferon-stimulated genes in the patients’ blood, typical for type I interferonopathies. Peripheral blood mononuclear cells from all three patients demonstrated elevated responses to innate immune stimuli, which could be reproduced in CRISPR–Cas9-generated BATF2-/- human monocytic cell lines. BATF2 is, therefore, a novel disease-associated gene for severe epilepsy and mental retardation, related to dysregulation of immune responses, which underscores the relevance of neuroinflammation for epilepsy.

ORGANISM(S): Homo sapiens

PROVIDER: GSE220916 | GEO | 2023/01/25

REPOSITORIES: GEO

Similar Datasets

| PRJNA120323 | ENA
2015-03-26 | GSE67258 | GEO
2011-03-05 | GSE20564 | GEO
2010-05-26 | E-GEOD-10189 | biostudies-arrayexpress
2008-02-17 | GSE10189 | GEO
2011-03-05 | E-GEOD-20564 | biostudies-arrayexpress
2023-08-31 | GSE235114 | GEO
2017-03-27 | GSE81724 | GEO
2009-12-16 | GSE19457 | GEO
2017-07-24 | GSE101781 | GEO